Abstract:Aging biomarkers can potentially allow researchers to rapidly monitor the impact of an aging intervention, without the need for decade-spanning trials, by acting as surrogate endpoints. Prior to testing whether aging biomarkers may be useful as surrogate endpoints, it is first necessary to determine whether they are responsive to interventions that target aging. Epigenetic clocks are aging biomarkers based on DNA methylation with prognostic value for many aging outcomes. Many individual studies are beginning to explore whether epigenetic clocks are responsive to interventions. However, the diversity of both interventions and epigenetic clocks in different studies make them difficult to compare systematically. Here, we curate TranslAGE-Response, a harmonized database of 51 public and private longitudinal interventional studies and calculate a consistent set of 16 prominent epigenetic clocks for each study, along with 95 other DNAm biomarkers that help explain changes in each clock. With this database, we discover patterns of responsiveness across a variety of interventions and DNAm biomarkers. For example, clocks trained to predict mortality or pace of aging have the strongest response across all interventions and show consistent agreement with each other, pharmacological and lifestyle interventions drive the strongest response from DNAm biomarkers, and study population and study duration are key factors in driving responsiveness of DNAm biomarkers in an intervention. Some classes of interventions such as TNF-alpha inhibitors have strong, consistent effects across multiple studies, while others such as senolytic drugs have inconsistent effects. Clocks with multiple sub-scores (i.e. "explainable clocks") provide specificity and greater mechanistic insight into responsiveness of interventions than single-score clocks. Our work can help the geroscience field design future clinical trials, by guiding the choice of interventions, specific subsets of epigenetic clocks to minimize multiple testing, study duration, study population, and sample size, with the eventual aim of determining whether epigenetic clocks can be used as surrogate endpoints.

Differential Responses of Dynamic and Entropic Aging Factors to Longevity Interventions

Discovery of Thermodynamic Control Variables that Independently Regulate Healthspan and Maximum Lifespan

Tick tock, tick tock: Mouse culture and tissue aging captured by an epigenetic clock

The Molecular Architecture of Variable Lifespan in Diversity Outbred Mice

Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers

Nonlinear DNA methylation trajectories in aging male mice

High-dimensional Ageome Representations of Biological Aging across Functional Modules

DNAm aging biomarkers are responsive: Insights from 51 longevity interventional studies in humans

DNA Break-Induced Epigenetic Drift as a Cause of Mammalian Aging

Collective dynamics of DNA methylation during ageing

DNA methylation entropy as a measure of stem cell replication and aging

Transcriptomic Hallmarks of Mortality Reveal Universal and Specific Mechanisms of Aging, Chronic Disease, and Rejuvenation

Longitudinal Fragility Phenotyping Predicts Lifespan and Age-Associated Morbidity in C57BL/6 and Diversity Outbred Mice

Longitudinal fragility phenotyping contributes to the prediction of lifespan and age-associated morbidity in C57BL/6 and Diversity Outbred mice

Characterization of a natural model of adult mice with different rate of aging

The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

A rat epigenetic clock recapitulates phenotypic aging and co-localizes with heterochromatin

Deep phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J mice

Negative Effects of Lifespan Extending Intervention on Resilience in Mice.

Age-related transcriptional changes in gene expression in different organs of mice support the metabolic stability theory of aging

Nonlinear dynamics of multi-omics profiles during human aging